| Price | $0.97 |
| Year Range | $0.86 – $1.65 |
| Market Cap | $12M |
| Industry | Biotechnology |
What Is Phio Pharmaceuticals’s AI Stock Analysis?
Phio Pharmaceuticals’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Phio Pharmaceuticals’s momentum in near-real time.
Phio Pharmaceuticals (PHIO) has an AltIndex AI Score of 52/100, currently a Hold signal. The AI Score distills Phio Pharmaceuticals's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Phio Pharmaceuticals’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Phio Pharmaceuticals — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving PHIO’s AI Score?
Fundamentals
Net income for the last quarter was $-4.1M. This represents a decrease of 3.37% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 91.04%, which may be a cause for concern. Ebitda for the last quarter was $-4.3M. This represents a decrease of 6.62% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 97.04%, which may be a cause for concern.
See Phio Pharmaceuticals’s earnings and insider transactions.
Technicals
Today's stock price is $0.97. This represents a decrease of 5.83% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 55.91%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $1.00, which is lower than the previous SMA10 of $1.00. This suggests a potential downward trend in price movement. The RSI is 38.9, indicating a neutral condition.
See the full technical analysis and price prediction.
Sentiment & social
The sentiment for the stock on various stock forums is neutral.
Track Phio Pharmaceuticals’s market sentiment.
Frequently Asked Questions: Phio Pharmaceuticals AI Stock Analysis
Phio Pharmaceuticals's AltIndex AI Score is 52/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Phio Pharmaceuticals a Hold (52/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Phio Pharmaceuticals — company overview, fundamentals, technicals and alternative data, with a recommendation. See the PHIO AI Score or sign up to read the full thesis.
